Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Macrophage Syk-PI3Kγ inhibits anti-tumor immunity: SRX3207, a novel dual Syk-PI3K inhibitory chemotype relieves tumor immunosuppression.

Joshi S, Liu KX, Zulcic M, Singh AR, Skola D, Glass CK, Sanders PD, Sharabi AB, Pham TV, Tamayo P, Shiang D, Dinh HQ, Hedrick CC, Morales GA, Garlich JR, Durden DL.

Mol Cancer Ther. 2020 Jan 23. pii: molcanther.0947.2019. doi: 10.1158/1535-7163.MCT-19-0947. [Epub ahead of print]

2.

Cannabinoids promote progression of HPV positive head and neck squamous cell carcinoma via p38 MAPK activation.

Liu C, Sadat SH, Ebisumoto K, Sakai A, Panuganti BA, Ren S, Goto Y, Haft S, Fukusumi T, Ando M, Saito Y, Guo T, Tamayo P, Yeerna H, Kim W, Hubbard J, Sharabi AB, Gutkind JS, Califano JA.

Clin Cancer Res. 2020 Jan 13. pii: clincanres.3301.2018. doi: 10.1158/1078-0432.CCR-18-3301. [Epub ahead of print]

3.

HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer.

Miyauchi S, Sanders PD, Guram K, Kim SS, Paolini F, Venuti A, Cohen EEW, Gutkind JS, Califano JA, Sharabi AB.

Cancer Res. 2020 Feb 15;80(4):732-746. doi: 10.1158/0008-5472.CAN-19-1771. Epub 2019 Dec 17.

PMID:
31848196
4.

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4.

Wang Z, Wu VH, Allevato MM, Gilardi M, He Y, Luis Callejas-Valera J, Vitale-Cross L, Martin D, Amornphimoltham P, Mcdermott J, Yung BS, Goto Y, Molinolo AA, Sharabi AB, Cohen EEW, Chen Q, Lyons JG, Alexandrov LB, Gutkind JS.

Nat Commun. 2019 Dec 5;10(1):5546. doi: 10.1038/s41467-019-13471-0.

5.

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy.

Guram K, Kim SS, Wu V, Sanders PD, Patel S, Schoenberger SP, Cohen EEW, Chen SY, Sharabi AB.

Front Immunol. 2019 Mar 18;10:491. doi: 10.3389/fimmu.2019.00491. eCollection 2019. Review.

6.

Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics.

Miyauchi S, Kim SS, Pang J, Gold KA, Gutkind JS, Califano JA, Mell LK, Cohen EEW, Sharabi AB.

Clin Cancer Res. 2019 Jul 15;25(14):4211-4223. doi: 10.1158/1078-0432.CCR-18-0871. Epub 2019 Feb 27. Review.

7.

Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response.

Guram K, Nunez M, Einck J, Mell LK, Cohen E, Sanders PD, Miyauchi S, Weihe E, Kurzrock R, Boles S, Sharabi AB.

Front Oncol. 2018 Oct 17;8:435. doi: 10.3389/fonc.2018.00435. eCollection 2018.

8.

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.

Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby MJ, Thudium KB, Korman AJ, Ulmert D, Thorek DLJ, DeWeese TL, Drake CG.

Clin Cancer Res. 2018 Oct 15;24(20):5058-5071. doi: 10.1158/1078-0432.CCR-17-3427. Epub 2018 Jun 13.

9.

TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors.

Francica BJ, Ghasemzadeh A, Desbien AL, Theodros D, Sivick KE, Reiner GL, Hix Glickman L, Marciscano AE, Sharabi AB, Leong ML, McWhirter SM, Dubensky TW Jr, Pardoll DM, Drake CG.

Cancer Immunol Res. 2018 Apr;6(4):422-433. doi: 10.1158/2326-6066.CIR-17-0263. Epub 2018 Feb 22.

10.

Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.

Bryant AK, Mundt RC, Sandhu AP, Urbanic JJ, Sharabi AB, Gupta S, Daly ME, Murphy JD.

Ann Thorac Surg. 2018 Feb;105(2):425-431. doi: 10.1016/j.athoracsur.2017.07.048. Epub 2017 Nov 30.

PMID:
29198624
11.

Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer.

Bryant AK, Mudgway R, Huynh-Le MP, Simpson DR, Mell LK, Gupta S, Sharabi AB, Murphy JD.

Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):478-485. doi: 10.1016/j.ijrobp.2017.09.034. Epub 2017 Sep 22.

12.

Association of HIV Status With Outcomes of Anal Squamous Cell Carcinoma in the Era of Highly Active Antiretroviral Therapy.

Bryant AK, Huynh-Le MP, Simpson DR, Gupta S, Sharabi AB, Murphy JD.

JAMA Oncol. 2018 Jan 1;4(1):120-122. doi: 10.1001/jamaoncol.2017.2844. No abstract available.

13.

Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.

Sharabi AB, Lim M, DeWeese TL, Drake CG.

Lancet Oncol. 2015 Oct;16(13):e498-509. doi: 10.1016/S1470-2045(15)00007-8. Review.

PMID:
26433823
14.

Stereotactic radiation therapy combined with immunotherapy: augmenting the role of radiation in local and systemic treatment.

Sharabi AB, Tran PT, Lim M, Drake CG, Deweese TL.

Oncology (Williston Park). 2015 May;29(5):331-40. Review.

15.

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen.

Sharabi AB, Nirschl CJ, Kochel CM, Nirschl TR, Francica BJ, Velarde E, Deweese TL, Drake CG.

Cancer Immunol Res. 2015 Apr;3(4):345-55. doi: 10.1158/2326-6066.CIR-14-0196. Epub 2014 Dec 19.

16.

Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer.

Raval RR, Sharabi AB, Walker AJ, Drake CG, Sharma P.

J Immunother Cancer. 2014 May 14;2:14. doi: 10.1186/2051-1426-2-14. eCollection 2014. Review.

17.

Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.

Wild AT, Hiniker SM, Chang DT, Tran PT, Khashab MA, Limaye MR, Laheru DA, Le DT, Kumar R, Pai JS, Hargens B, Sharabi AB, Shin EJ, Zheng L, Pawlik TM, Wolfgang CL, Koong AC, Herman JM.

J Gastrointest Oncol. 2013 Dec;4(4):343-51. doi: 10.3978/j.issn.2078-6891.2013.044.

18.

Enhanced generation of myeloid lineages in hematopoietic differentiation from embryonic stem cells by silencing transcriptional repressor Twist-2.

Sharabi AB, Lee SH, Goodell MA, Huang XF, Chen SY.

Cloning Stem Cells. 2009 Dec;11(4):523-33. doi: 10.1089/clo.2009.0020.

19.

Twist-2 controls myeloid lineage development and function.

Sharabi AB, Aldrich M, Sosic D, Olson EN, Friedman AD, Lee SH, Chen SY.

PLoS Biol. 2008 Dec 16;6(12):e316. doi: 10.1371/journal.pbio.0060316.

Supplemental Content

Loading ...
Support Center